# ZEMAIRA

NDC: 57516-101
Generic name: alpha-1-proteinase inhibitor human kit
Labeler / Manufacturer: Fisher Clinical Services Inc.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: KIT
Routes: INTRAVENOUS
Marketing started: 20220222

FDA application: BLA125078

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57516-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57516-101